Sanderson M C, Swartzendruber D J, Fenoglio M E, Moore J T, Haun W E
Department of Surgery, Presbyterian/St. Luke's Medical Center, Denver, Colorado.
Am J Surg. 1990 Dec;160(6):561-5; discussion 565-6. doi: 10.1016/s0002-9610(05)80746-9.
Surgical experience with 260 consecutive patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis (CAPD) at one medical center from 1980 to 1989 is reviewed. Patients received CAPD for a mean of 24.2 months (range: 3 days to 91 months). Catheter longevity consistently improved in all but 1 year from 1984 to 1989, as did exit-site and tunnel infections. Of 311 catheters inserted, 151 (49%) required removal, of which 111 (74%) were attributed to peritonitis. Cumulative patient survival was 80%, 60%, and 53% at 1, 2, and 3 years, respectively. Diabetic patients had statistically significant lower survival rates. Additional complications including catheter leakage, catheter malposition, catheter obstruction, and abdominal wall hernias were negligible. Although CAPD is not free from serious complications, our data show remarkable improvement since 1980 in catheter longevity, hospital stay, and infection rates.
回顾了1980年至1989年期间，在一家医疗中心连续260例接受持续性非卧床腹膜透析（CAPD）的慢性肾衰竭患者的手术经验。患者接受CAPD的平均时间为24.2个月（范围：3天至91个月）。除了1984年至1989年中的1年外，导管使用寿命在所有年份均持续改善，出口部位和隧道感染情况也是如此。在插入的311根导管中，151根（49%）需要拔除，其中111根（74%）归因于腹膜炎。1年、2年和3年时的累积患者生存率分别为80%、60%和53%。糖尿病患者的生存率在统计学上显著较低。包括导管渗漏、导管位置不当、导管阻塞和腹壁疝在内的其他并发症可忽略不计。虽然CAPD并非没有严重并发症，但我们的数据显示，自1980年以来，导管使用寿命、住院时间和感染率有了显著改善。
